|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00681525 |
|
Date of registration:
|
19/05/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
April 2008 |
|
Target sample size:
|
18 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00681525 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 1
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Healthy male or female subjects
Exclusion Criteria:
- Clinically significant diseases or disorders
- Positive screens for drug and alcohol
- Pregnant or breast-feeding females
- Any history of surgery(ies) that might interfere with the gastrointestinal motility,
pH or absorption
Age minimum:
18 Years
Age maximum:
55 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Pharmacokinetics
|
|
Intervention(s)
|
|
Drug: Atorvastatin
|
|
Drug: ABT-335
|
|
Drug: Ezetimibe
|
|
Primary Outcome(s)
|
|
PK interaction
[Time Frame: Study duration approximately 62 days]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|